19/07/2020
Coronil Again under controversy!
Madras HC restraints Patanjali from using 'Coronil' after Chennai-based co. claims rights.
*Madras High Court restrains Patanjali from using 'Coronil' trademark till July 30*
Patanjali's Coronil, which was previously involved in a controversy over its claims to cure Covid-19, has now been restrained from using the trademark Coronil by Madras High Court. This comes after a Chennai-based firm's objection.
Justice C V Karthikeyan passed an interim order restraining Patanjali from using the name ‘Coronil’ till July 30, the report said, adding that the order was passed on a petition filed by Chennai-based Arudra Engineering Private Limited, which claims it has ownership over the name "Coronil" since 1993.
According to the company which is into manufacturing chemicals and sanitisers to clean heavy machineries and containment units, it has registere ‘Coronil-213 SPL’ and ‘Coronil-92B’ in 1993 and has been diligently renewing the trademark since then.
The company argued that their clients include public sector undertakings like Indian Oil and Bharat Heavy Electricals Limited (BHEL). The company, Arudra Engineering, produced sales bills to strengthen their claim that the name "Coronil" had been in use for over three decades, the report said.
“The mark adopted by Patanjali for its drugs are clearly identical to the marks registered by the company. Though the products sold by the company are different, use of identical trademarks would still amount to infringement of our intellectual property right,” the company said.
“Permitting Patanjali to continue to use the mark will directly affect our reputation and the goodwill created over the mark for over 26 years in both international and domestic markets,” the petitioner added.
